Crimson carrier, A long‐acting contrast agent for in vivo near‐infrared imaging of injured and diseased muscle
暂无分享,去创建一个
L. McManus | C. Keller | J. Michalek | B. Rubin | Jinu Abraham | P. Shireman | Suresh I. Prajapati | A. T. McCleish | Carlo O. Martinez | Amanda T. McCleish
[1] Therapeutic potential of targeting haploinsufficient genes in cancer , 2009, Pediatric blood & cancer.
[2] M. Scott,et al. Bortezomib reverses a post‐translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma , 2009, Pediatric blood & cancer.
[3] Ali N. Bahadur,et al. Biomarker System for Studying Muscle, Stem Cells, and Cancer in Vivo Generation of Dual-modality Bioreporter Mouse Line , 2009 .
[4] Ali N. Bahadur,et al. Near-Infrared Imaging of Injured Tissue in Living Subjects Using IR-820 , 2009, Molecular imaging.
[5] Kathryn E. Luker,et al. Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.
[6] Paula K Shireman,et al. Delayed angiogenesis and VEGF production in CCR2-/- mice during impaired skeletal muscle regeneration. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[7] Vasilis Ntziachristos,et al. Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Harris,et al. Myotoxic phospholipases A2 and the regeneration of skeletal muscles. , 2003, Toxicon : official journal of the International Society on Toxinology.